Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Zhang Li, Ming Li, Pengcheng Xia, Lili Wang & Zhiming Lu. (2022) Targeting long non-coding RNA PVT1/TGF-β/Smad by p53 prevents glioma progression. Cancer Biology & Therapy 23:1, pages 225-233.
Read now
Read now
Anne Clavreul, Emilie Roger, Milad Pourbaghi-Masouleh, Laurent Lemaire, Clément Tétaud & Philippe Menei. (2018) Development and characterization of sorafenib-loaded lipid nanocapsules for the treatment of glioblastoma. Drug Delivery 25:1, pages 1756-1765.
Read now
Read now
Articles from other publishers (39)
Meihui Huang, Jiajian Xue, Zhiming Chen, Xiao Zhou, Mantong Chen, Jianhong Sun, Zhennan Xu, Shaohong Wang, Haixiong Xu, Zepeng Du & Mingfa Liu. (2023) MTHFD2 suppresses glioblastoma progression via the inhibition of ERK1/2 phosphorylation. Biochemistry and Cell Biology 101:1, pages 112-124.
Crossref
Crossref
Mengya Zhao, Xiaodong Li, Yijun Chen & Shuzhen Wang. (2022) MD2 Is a Potential Biomarker Associated with Immune Cell Infiltration in Gliomas. Frontiers in Oncology 12.
Crossref
Crossref
Zhiqiang Dong, Jinglong Zhang, Liang Niu, Guokuo Hou, Zhenshan Gao & Qiang Yang. (2021) miR-381-3p Involves in Glioma Progression by Suppressing Tumor-Promoter Factor ANTXR1. Computational and Mathematical Methods in Medicine 2021, pages 1-7.
Crossref
Crossref
Humaira Noor, Ashraf Zaman, Charles Teo & Michael E. Sughrue. (2021) PODNL1 Methylation Serves as a Prognostic Biomarker and Associates with Immune Cell Infiltration and Immune Checkpoint Blockade Response in Lower-Grade Glioma. International Journal of Molecular Sciences 22:22, pages 12572.
Crossref
Crossref
Paula Aldaz & Imanol Arozarena. (2021) Tyrosine Kinase Inhibitors in Adult Glioblastoma: An (Un)Closed Chapter?. Cancers 13:22, pages 5799.
Crossref
Crossref
Humaira Noor, Nancy E. Briggs, Kerrie L. McDonald, Jeff Holst & Orazio Vittorio. (2021) TP53 Mutation Is a Prognostic Factor in Lower Grade Glioma and May Influence Chemotherapy Efficacy. Cancers 13:21, pages 5362.
Crossref
Crossref
A. A. Mitrofanov, D. R. Naskhletashvili, V. A. Aleshin, D. M. Belov, A. Kh. Bekyashev, V. B. Karakhan, N. V. Sevyan, E. V. Prozorenko & K. E. Roshchina. (2021) Causes of drug resistance and glioblastoma relapses. Head and Neck Tumors (HNT) 11:1, pages 101-108.
Crossref
Crossref
Haitao Wen, Zhenwei Li, Sirong Song, Lixia Xu, Xiaoguang Tong & Hua Yan. (2021)
Silencing of lncRNA LBX2-AS1 suppresses glioma cell proliferation and metastasis through the Akt/GSK3β pathway
in vitro
. Acta Biochimica et Biophysica Sinica 53:4, pages 446-453.
Crossref
Crossref
Wei Zhao, Xiaoyan Lin, Han Han, Hongxu Zhang, Xiaoli Li, Chunming Jiang & Mei Feng. (2021) Long noncoding RNA H19 contributes to the proliferation and autophagy of glioma cells through mTOR/ULK1 pathway. NeuroReport 32:5, pages 352-358.
Crossref
Crossref
Mei Zhang, Sajid Asghar, Cihui Tian, Ziyi Hu, Qineng Ping, Zhipeng Chen, Feng Shao & Yanyu Xiao. (2021) Lactoferrin/phenylboronic acid-functionalized hyaluronic acid nanogels loading doxorubicin hydrochloride for targeting glioma. Carbohydrate Polymers 253, pages 117194.
Crossref
Crossref
Jing Li, Jun Jiang, Jianmei Wu, Xun Bao & Nader Sanai. (2020) Physiologically Based Pharmacokinetic Modeling of Central Nervous System Pharmacokinetics of CDK4/6 Inhibitors to Guide Selection of Drug and Dosing Regimen for Brain Cancer Treatment. Clinical Pharmacology & Therapeutics 109:2, pages 494-506.
Crossref
Crossref
Jae-Hong Kim, Yeojin Seo, Myungjin Jo, Hyejin Jeon, Young-Seop Kim, Eun-Jung Kim, Donggun Seo, Won-Ha Lee, Sang Ryong Kim, Nozomu Yachie, Quan Zhong, Marc Vidal, Frederick P. Roth & Kyoungho Suk. (2020) Interrogation of kinase genetic interactions provides a global view of PAK1-mediated signal transduction pathways. Journal of Biological Chemistry 295:50, pages 16906-16919.
Crossref
Crossref
Tuo Wang, Yan Zhang, Bo Cui, Maode Wang, Ya Li & Ke Gao. (2020) miR-4530 inhibits the malignant biological behaviors of human glioma cells by directly targeting. Acta Biochimica et Biophysica Sinica 52:12, pages 1394-1403.
Crossref
Crossref
Lianglong Zhang, Feng Wu & Jian Zhao. (2020) Transmembrane protein 45A regulates the proliferation, migration, and invasion of glioma cells through nuclear factor kappa-B. Anti-Cancer Drugs 31:9, pages 900-907.
Crossref
Crossref
Peng Chen, Guangying Zhang, Qin Zhou & Zhanzhan Li. (2020) Plasma microRNA-720 may predict prognosis and diagnosis in glioma patients. Bioscience Reports 40:7.
Crossref
Crossref
Hang Cao, Xuejun Li, Feiyifan Wang, Yueqi Zhang, Yi Xiong & Qi Yang. (2020) Phytochemical-Mediated Glioma Targeted Treatment: Drug Resistance and Novel Delivery Systems. Current Medicinal Chemistry 27:4, pages 599-629.
Crossref
Crossref
Jin Shi, Shigang Lv, Miaojing Wu, Xianggan Wang, Yan Deng, Yansheng Li, Kuanxun Li, Hongyu Zhao, Xingen Zhu & Minhua Ye. (2020) HOTAIR‐EZH2 inhibitor AC1Q3QWB upregulates CWF19L1 and enhances cell cycle inhibition of CDK4/6 inhibitor palbociclib in glioma. Clinical and Translational Medicine 10:1, pages 182-198.
Crossref
Crossref
Xinwen Lv, Chunyan Gu & Shiwen Guo. (2020) Activation of BDNF-AS/ADAR/p53 Positive Feedback Loop Inhibits Glioblastoma Cell Proliferation. Neurochemical Research 45:2, pages 508-518.
Crossref
Crossref
Angelica Benavides-Serrato, Jacquelyn T. Saunders, Brent Holmes, Robert N. Nishimura, Alan Lichtenstein & Joseph Gera. (2020) Repurposing Potential of Riluzole as an ITAF Inhibitor in mTOR Therapy Resistant Glioblastoma. International Journal of Molecular Sciences 21:1, pages 344.
Crossref
Crossref
Hongliang Wang, Feng Tang, Erbao Bian, Yile Zhang, Xinghu Ji, Zhihao Yang & Bing Zhao. (2019) IFITM3/STAT3 axis promotes glioma cells invasion and is modulated by TGF-β. Molecular Biology Reports 47:1, pages 433-441.
Crossref
Crossref
Beatrix Wulkersdorfer, Martin Bauer, Rudolf Karch, Harald Stefanits, Cécile Philippe, Maria Weber, Thomas Czech, Marie-Claude Menet, Xavier Declèves, Johannes A. Hainfellner, Matthias Preusser, Marcus Hacker, Markus Zeitlinger, Markus Müller & Oliver Langer. (2019) Assessment of brain delivery of a model ABCB1/ABCG2 substrate in patients with non-contrast-enhancing brain tumors with positron emission tomography. EJNMMI Research 9:1.
Crossref
Crossref
Fatih M. Uckun, Sanjive Qazi, Larn Hwang & Vuong N. Trieu. (2019) Recurrent or Refractory High-Grade Gliomas Treated by Convection-Enhanced Delivery of a TGFβ2-Targeting RNA Therapeutic: A Post-Hoc Analysis with Long-Term Follow-Up. Cancers 11:12, pages 1892.
Crossref
Crossref
Xiao‑Hui Zhai, Jian Xiao, Jie‑Kai Yu, Hong Sun & Shu Zheng. (2019) Novel sphingomyelin biomarkers for brain glioma and associated regulation research on the PI3K/Akt signaling pathway. Oncology Letters.
Crossref
Crossref
Michael W. Graner. (2019) Roles of Extracellular Vesicles in High-Grade Gliomas: Tiny Particles with Outsized Influence. Annual Review of Genomics and Human Genetics 20:1, pages 331-357.
Crossref
Crossref
Xiang Xu, Jiadi Xu, Linda Knutsson, Jing Liu, Huanling Liu, Yuguo Li, Bachchu Lal, John Laterra, Dmitri Artemov, Guanshu Liu, Peter C. M. van Zijl & Kannie W. Y. Chan. (2019) The effect of the mTOR inhibitor rapamycin on glucoCEST signal in a preclinical model of glioblastoma. Magnetic Resonance in Medicine 81:6, pages 3798-3807.
Crossref
Crossref
Anna M. Krichevsky & Erik J. Uhlmann. (2019) Oligonucleotide Therapeutics as a New Class of Drugs for Malignant Brain Tumors: Targeting mRNAs, Regulatory RNAs, Mutations, Combinations, and Beyond. Neurotherapeutics 16:2, pages 319-347.
Crossref
Crossref
Michel Desjarlais & Borhane Annabi. (2019) Dual functions of ARP101 in targeting membrane type-1 matrix metalloproteinase: Impact on U87 glioblastoma cell invasion and autophagy signaling. Chemical Biology & Drug Design 93:3, pages 272-282.
Crossref
Crossref
Anja Smits & Asgeir S. Jakola. (2019) Clinical Presentation, Natural History, and Prognosis of Diffuse Low-Grade Gliomas. Neurosurgery Clinics of North America 30:1, pages 35-42.
Crossref
Crossref
Zheng Hao, Si Hu, Zheng Liu, Weixin Song, Yeyu Zhao & Meihua Li. (2018) Circular RNAs: Functions and Prospects in Glioma. Journal of Molecular Neuroscience 67:1, pages 72-81.
Crossref
Crossref
Priscilla K. Brastianos, Franziska Maria Ippen, Umbreen Hafeez & Hui K. Gan. (2018) Emerging Gene Fusion Drivers in Primary and Metastatic Central Nervous System Malignancies: A Review of Available Evidence for Systemic Targeted Therapies. The Oncologist 23:9, pages 1063-1075.
Crossref
Crossref
Marike L. Broekman, Sybren L. N. Maas, Erik R. Abels, Thorsten R. Mempel, Anna M. Krichevsky & Xandra O. Breakefield. (2018) Multidimensional communication in the microenvirons of glioblastoma. Nature Reviews Neurology 14:8, pages 482-495.
Crossref
Crossref
Joseph Scafidi, Jonathan Ritter, Brooke M. Talbot, Jorge Edwards, Li-Jin Chew & Vittorio Gallo. (2018) Age-Dependent Cellular and Behavioral Deficits Induced by Molecularly Targeted Drugs Are Reversible. Cancer Research 78:8, pages 2081-2095.
Crossref
Crossref
Rafał Kampa, Ilona Bednarek & Daniel Sypniewski. (2018) Monoclonal antibodies in regulation of signal transduction
of Epidermal Growth Factor Receptor (EGFR) pathway in cancer cells. Annales Academiae Medicae Silesiensis 72, pages 12-20.
Crossref
Crossref
Quanye Sun, Chunying Pei, Qiuyuan Li, Tianxiu Dong, Yucui Dong, Wenjing Xing, Peng Zhou, Yujiao Gong, Ziqi Zhen, Yifan Gao, Yun Xiao, Jun Su & Huan Ren. (2018) Up-regulation of MSH6 is associated with temozolomide resistance in human glioblastoma. Biochemical and Biophysical Research Communications 496:4, pages 1040-1046.
Crossref
Crossref
Xiaoyan He, Mayinur Maimaiti, Yan Jiao, Xuegang Meng & Hongyan Li. (2018) Sinomenine Induces G1-Phase Cell Cycle Arrest and Apoptosis in Malignant Glioma Cells Via Downregulation of Sirtuin 1 and Induction of p53 Acetylation. Technology in Cancer Research & Treatment 17, pages 153303461877030.
Crossref
Crossref
Fabliha Ahmed Chowdhury, Md Kamal Hossain, A. G. M. Mostofa, Maruf Mohammad Akbor & Muhammad Shahdaat Bin Sayeed. (2018) Therapeutic Potential of Thymoquinone in Glioblastoma Treatment: Targeting Major Gliomagenesis Signaling Pathways. BioMed Research International 2018, pages 1-15.
Crossref
Crossref
Zoltán Hujber, Gábor Petővári, Norbert Szoboszlai, Titanilla Dankó, Noémi Nagy, Csilla Kriston, Ildikó Krencz, Sándor Paku, Olivér Ozohanics, László Drahos, András Jeney & Anna Sebestyén. (2017) Rapamycin (mTORC1 inhibitor) reduces the production of lactate and 2-hydroxyglutarate oncometabolites in IDH1 mutant fibrosarcoma cells. Journal of Experimental & Clinical Cancer Research 36:1.
Crossref
Crossref
Zhi-Gang Yao, Wen-Huan Li, Fang Hua, Hong-Xia Cheng, Miao-Qing Zhao, Xi-Chao Sun, Ye-Jun Qin & Jia-Mei Li. (2017) LBH589 Inhibits Glioblastoma Growth and Angiogenesis Through Suppression of HIF-1α Expression. Journal of Neuropathology & Experimental Neurology 76:12, pages 1000-1007.
Crossref
Crossref
Patrick Y. WenSusan M. ChangMartin J. Van den BentMichael A. VogelbaumDavid R. MacdonaldEudocia Q. Lee. (2017) Response Assessment in Neuro-Oncology Clinical Trials. Journal of Clinical Oncology, pages JCO.2017.72.751.
Crossref
Crossref